- In March 2025, Abbott Laboratories launched the next-generation FreeStyle Libre 3 continuous glucose monitoring system across key Asia-Pacific markets, offering enhanced accuracy, real-time glucose data, and improved user convenience. This launch is expected to accelerate the adoption of continuous glucose monitoring (CGM) devices in the region, especially among patients seeking non-invasive, easy-to-use diabetes management solutions.
- In January 2025, Medtronic announced a strategic partnership with a leading Indian healthcare provider to expand access to its Guardian Connect CGM system. The collaboration aims to integrate Medtronic’s advanced glucose monitoring technology with telemedicine platforms, improving remote diabetes care and monitoring capabilities across urban and rural India.
- In October 2024, Dexcom expanded its presence in China by launching its G7 CGM system, featuring a smaller sensor and longer wear time. The product launch aligns with China’s growing focus on digital health innovation and government support for chronic disease management, which is expected to significantly boost demand for advanced glucose monitoring devices.
- In September 2024, Roche Diagnostics introduced its Accu-Chek Solo micropump and glucose monitoring integration in several Asia-Pacific countries, emphasizing seamless connectivity and ease of use. This development caters to the rising need for integrated diabetes management systems, fostering better glycemic control and patient adherence
